InfuSystem Holdings Files 8-K for Regulation FD Disclosure
Ticker: INFU · Form: 8-K · Filed: Sep 25, 2025 · CIK: 1337013
| Field | Detail |
|---|---|
| Company | Infusystem Holdings, INC (INFU) |
| Form Type | 8-K |
| Filed Date | Sep 25, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, Regulation FD, Disclosure
TL;DR
InfuSystem Holdings filed an 8-K for a Reg FD disclosure. Details TBD.
AI Summary
InfuSystem Holdings, Inc. filed an 8-K on September 25, 2025, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, only that it is a current report.
Why It Matters
This filing indicates InfuSystem Holdings is making a public disclosure under Regulation FD, which ensures all investors receive material information at the same time.
Risk Assessment
Risk Level: low — This is a standard regulatory filing with no immediate indication of negative events.
Key Players & Entities
- InfuSystem Holdings, Inc. (company) — Registrant
- September 25, 2025 (date) — Date of Report
- Regulation FD (regulation) — Type of Disclosure
- 3851 West Hamlin Road, Rochester Hills, Michigan 48309 (address) — Principal Executive Offices
- 001-35020 (filing_number) — SEC File Number
FAQ
What specific information is being disclosed under Regulation FD?
The filing does not specify the content of the Regulation FD disclosure, only that one is being made.
When was this 8-K filing submitted?
The 8-K filing was submitted on September 25, 2025.
What is the primary purpose of this 8-K filing?
The primary purpose is to report a Regulation FD Disclosure.
What is the principal executive office address for InfuSystem Holdings, Inc.?
The principal executive office is located at 3851 West Hamlin Road, Rochester Hills, Michigan 48309.
What is the SEC file number for InfuSystem Holdings, Inc.?
The SEC file number is 001-35020.
Filing Stats: 542 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-09-25 16:26:35
Filing Documents
- infu-20250925.htm (8-K) — 27KB
- exhibit99109-25x2025rothhe.htm (EX-99.1) — 11KB
- infusystem_safesmarttrustea.jpg (GRAPHIC) — 760KB
- 0001628280-25-042799.txt ( ) — 1193KB
- infu-20250925.xsd (EX-101.SCH) — 2KB
- infu-20250925_lab.xml (EX-101.LAB) — 21KB
- infu-20250925_pre.xml (EX-101.PRE) — 12KB
- infu-20250925_htm.xml (XML) — 3KB
01 - Regulation FD Disclosure
Item 7.01 - Regulation FD Disclosure On September 25, 2025 , InfuSystem Holdings, Inc. (the "Company") issued a press release announcing that Carrie Lachance, President and Chief Executive Officer, and Barry Steele, Chief Financial Officer, will participate at 4 th Annual ROTH Healthcare Opportunities Conference on Thursday, October 9, 2025. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this Item 7.01 — "Regulation FD Disclosure" of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release of InfuSystem Holdings, Inc. dated September 25, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INFUSYSTEM HOLDINGS, INC. By: /s/ Barry Steele Barry Steele Chief Financial Officer Dated: September 25, 2025